Minoxidil cho Rụng Tóc Kiểu Nữ

References

1. [1] Caitlin A Kearney et al.. Am J Clin Dermatol. 2026. Androgenetic Alopecia in Women: A Narrative Review of Pathophysiology, Clinical Evaluation, and Treatments. doi:10.1007/s40257-026-01009-2 PubMed
2. [2] Aditya K Gupta et al.. Expert Opin Pharmacother. 2026. Low-dose oral minoxidil (LDOM) and topical minoxidil: consensus recommendations for managing male and female pattern Hair loss in Hair transplant … doi:10.1080/14656566.2026.2642216 PubMed
3. [3] Michael M Ong et al.. J Am Acad Dermatol. 2025. Antiandrogen therapy for the treatment of female pattern hair loss: A clinical review of current and emerging therapies. doi:10.1016/j.jaad.2025.04.074 PubMed
4. [4] Pimpakarn Werachattawatchai et al.. Int J Womens Dermatol. 2025. Efficacy and safety of oral spironolactone for female pattern hair loss in premenopausal women: a randomized, double-blind, placebo-controlled, parallel-group pilot … doi:10.1097/JW9.0000000000000227 PubMed
5. [5] Juan Jimenez-Cauhe et al.. J Am Acad Dermatol. 2025. Spironolactone reduces the risk of low-dose oral minoxidil-induced edema in women with female pattern hair loss. doi:10.1016/j.jaad.2024.12.048 PubMed
6. [6] Ricardo da Silva Libório et al.. JAAD Int. 2025. Bicalutamide 25 mg combined with minoxidil 1 mg versus minoxidil 1 mg for female pattern hair loss: A randomized double-blind … doi:10.1016/j.jdin.2024.12.002 PubMed
7. [7] Laxmi Iyengar et al.. Aust Prescr. 2025. Male and female pattern hair loss. doi:10.18773/austprescr.2025.020 PubMed
8. [8] Nermeen Ibrahim Bedair et al.. Clin Exp Dermatol. 2025. Efficacy and safety of combined topical estradiol with minoxidil vs. topical minoxidil in female pattern hair loss: a trichoscopic randomized … doi:10.1093/ced/llae436 PubMed
9. [9] Yinfeng Xia et al.. Front Med (Lausanne). 2025. Relative efficacy of minoxidil in combination with other treatments for androgenic alopecia: a network meta-analysis based on randomized controlled trials. doi:10.3389/fmed.2025.1638496 PubMed
10. [10] Denise Ferreira Rodrigues et al.. Lasers Med Sci. 2025. Photobiomodulation therapy and 5% minoxidil in female pattern hair loss: a case series focusing on hair growth phases over a … doi:10.1007/s10103-025-04780-6 PubMed
11. [11] Naglaa Mohamad Al Sayed et al.. Dermatol Pract Concept. 2025. Clinical and Trichoscopic Evaluations of Topical Finasteride 1%, Topical Spironolactone 5%, and Minoxidil 5% in Female Pattern Hair Loss Treatment. doi:10.5826/dpc.1501a4698 PubMed
12. [12] Daniella Kushnir-Grinbaum et al.. J Am Acad Dermatol. 2025. Continued year-on-year improvement in hair density with systemic minoxidil in women with female pattern hair loss: A case series. doi:10.1016/j.jaad.2025.03.028 PubMed
13. [13] Jung-Won Shin et al.. Ann Dermatol. 2025. Updates in Treatment for Androgenetic Alopecia. doi:10.5021/ad.25.042 PubMed
14. [14] Rachita Dhurat et al.. J Cosmet Dermatol. 2025. Real-World Efficacy and Safety of Cuticapil Stem Hair Serum as an Add-On to Minoxidil in Androgenetic Alopecia: A Prospective Observational … doi:10.1111/jocd.70247 PubMed
15. [15] Ghada Fawzy Rezk Hassan et al.. Int J Trichology. 2025. Evaluation of the Efficacy and Safety of Topical Spironolactone versus Topical Minoxidil in the Treatment of Female Pattern Hair Loss: … doi:10.4103/ijt.ijt_118_23 PubMed
16. [16] Rocío Gil-Redondo et al.. JAAD Int. 2025. Improvement of female pattern hair loss with bicalutamide: A time-dependent process. doi:10.1016/j.jdin.2025.07.008 PubMed
17. [17] Nicole Yoong et al.. J Am Acad Dermatol. 2025. Combination of oral minoxidil and bicalutamide for the treatment of female pattern hair loss in adolescents. doi:10.1016/j.jaad.2025.01.056 PubMed
18. [18] Adam Leavitt et al.. J Drugs Dermatol. 2025. Addressing the Root Causes of Female Hair Loss and Non-Pharmaceutical Interventions. doi:10.36849/JDD.8763 PubMed
19. [19] Ali Asilian et al.. J Cosmet Dermatol. 2024. Clinical efficacy and safety of low-dose oral minoxidil versus topical solution in the improvement of androgenetic alopecia: A randomized controlled … doi:10.1111/jocd.16086 PubMed
20. [20] Sasithorn Limsuwan et al.. Front Vet Sci. 2024. Pharmacokinetics behavior of four cannabidiol preparations following single oral administration in dogs. doi:10.3389/fvets.2024.1389810 PubMed
21. [21] Afsaneh Sadeghzadeh Bazargan et al.. J Cosmet Dermatol. 2024. The efficacy of the combination of topical minoxidil and oral spironolactone compared with the combination of topical minoxidil and oral … doi:10.1111/jocd.15979 PubMed
22. [22] Lifang Hu et al.. Skin Res Technol. 2024. Efficacy and safety of botulinum toxin A in the treatment of female pattern hair loss. doi:10.1111/srt.13696 PubMed
23. [23] Aditya K Gupta et al.. J Cosmet Dermatol. 2024. The relative effect of monotherapy with 5-alpha reductase inhibitors and minoxidil for female pattern hair loss: A network meta-analysis study. doi:10.1111/jocd.15910 PubMed
24. [24] Xianhong Yang et al.. Photodiagnosis Photodyn Ther. 2024. Comparative efficacy of 2% minoxidil alone against combination of 2% minoxidil and low-level laser therapy in female pattern hair loss-A … doi:10.1016/j.pdpdt.2024.103966 PubMed
25. [25] Aditya K Gupta et al.. Expert Opin Pharmacother. 2024. Efficacy and safety of low-dose oral minoxidil in the management of androgenetic alopecia. doi:10.1080/14656566.2024.2314087 PubMed
26. [26] Abhijeet Kumar Jha et al.. Australas J Dermatol. 2024. Efficacy and safety of spironolactone versus bicalutamide in female pattern hair loss: A retrospective comparative study. doi:10.1111/ajd.14306 PubMed
27. [27] Deesha D Desai et al.. Arch Dermatol Res. 2024. Comparative analysis of low-dose oral minoxidil with spironolactone versus finasteride or dutasteride in female androgenetic alopecia management. doi:10.1007/s00403-024-03361-x PubMed
28. [28] Adriana C Corrêa et al.. Arch Dermatol Res. 2024. Split-scalp pilot study to evaluate effectiveness of Minoxidil 0,5% MMP® versus Topical Minoxidil 5% in the treatment of Female Pattern … doi:10.1007/s00403-024-03053-6 PubMed
29. [29] Arveen Shokravi et al.. SAGE Open Med Case Rep. 2024. Facial hair enhancement with minoxidil-an off-label use. doi:10.1177/2050313X241231490 PubMed
30. [30] Ambika Nohria et al.. JAAD Int. 2024. Improving efficacy and maintaining safety in the treatment of alopecia with low-dose oral minoxidil and spironolactone combination therapy: A retrospective … doi:10.1016/j.jdin.2024.07.023 PubMed
31. [31] Paul Gressenberger et al.. Skin Res Technol. 2024. Low dose oral minoxidil for the treatment of female pattern hair loss. doi:10.1111/srt.70013 PubMed
32. [32] Shivali Devjani et al.. Drugs. 2023. Androgenetic Alopecia: Therapy Update. doi:10.1007/s40265-023-01880-x PubMed
33. [33] Paulo Müller Ramos et al.. An Bras Dermatol. 2023. Female-pattern hair loss: therapeutic update. doi:10.1016/j.abd.2022.09.006 PubMed
34. [34] Abigail Meyers et al.. Aesthetic Plast Surg. 2023. Platelet-Rich Plasma for Treatment of Hair Loss Improves Patient-Reported Quality of Life. doi:10.1007/s00266-022-03224-8 PubMed
35. [35] Niloufar Najar Nobari et al.. Adv Clin Exp Med. 2023. A systematic review of clinical trials using single or combination therapy of oral or topical finasteride for women in reproductive … doi:10.17219/acem/157990 PubMed
36. [36] Akshunna Keerti et al.. Cureus. 2023. Topical Finasteride: A Comprehensive Review of Androgenetic Alopecia Management for Men and Women. doi:10.7759/cureus.44949 PubMed
37. [37] Rita Fernanda Cortez de Almeida et al.. Skin Appendage Disord. 2023. Scalp Microinfusion: A Novel Drug Delivery Technique for Hair Loss Treatment. doi:10.1159/000528446 PubMed
38. [38] Reese Imhof et al.. JAAD Int. 2023. Safety and tolerability of low dose oral minoxidil monotherapy in female pattern hair loss: A retrospective review with longitudinal ambulatory … doi:10.1016/j.jdin.2023.08.002 PubMed
39. [39] Kiran Godse et al.. Int J Trichology. 2023. Low-dose Oral Minoxidil in the Treatment of Alopecia: Evidence and Experience-based Consensus Statement of Indian Experts. doi:10.4103/ijt.ijt_70_23 PubMed
40. [40] Shreya Deoghare et al.. J Cosmet Laser Ther. 2023. Combination therapy in female pattern hair loss. doi:10.1080/14764172.2023.2222942 PubMed
41. [41] Akanksha Agarwal et al.. Indian J Dermatol. 2023. Comparative Efficacy of Topical Minoxidil Alone Against Combination of Topical Minoxidil and Platelet Rich Plasma in Women with Female Pattern … doi:10.4103/ijd.ijd_461_22 PubMed
42. [42] Seyed Mohammad Kazem Alavi et al.. Expert Rev Clin Pharmacol. 2023. Therapeutic effects of topical cetirizine in the treatment of female pattern hair loss: a randomized controlled noninferiority trial. doi:10.1080/17512433.2023.2243813 PubMed
43. [43] A K Gupta et al.. J Dermatolog Treat. 2022. Minoxidil: a comprehensive review. doi:10.1080/09546634.2021.1945527 PubMed
44. [44] Aditya K Gupta et al.. J Dermatolog Treat. 2022. Comparison of oral minoxidil, finasteride, and dutasteride for treating androgenetic alopecia. doi:10.1080/09546634.2022.2109567 PubMed
45. [45] Dmitri Wall et al.. Fac Rev. 2022. Advances in hair growth. doi:10.12703/r/11-1 PubMed
46. [46] Aditya K Gupta et al.. J Cosmet Dermatol. 2022. Topical finasteride for male and female pattern hair loss: Is it a safe and effective alternative? doi:10.1111/jocd.14895 PubMed
47. [47] Raquel de Melo Carvalho et al.. J Cosmet Dermatol. 2022. Bicalutamide and the new perspectives for female pattern hair loss treatment: What dermatologists should know. doi:10.1111/jocd.14773 PubMed
48. [48] L Bokhari et al.. J Eur Acad Dermatol Venereol. 2022. Sublingual minoxidil for the treatment of male and female pattern hair loss: a randomized, double-blind, placebo-controlled, phase 1B clinical trial. doi:10.1111/jdv.17623 PubMed
49. [49] Pietro Gentile et al.. J Plast Reconstr Aesthet Surg. 2022. Systematic review: The platelet-rich plasma use in female androgenetic alopecia as effective autologous treatment of regenerative plastic surgery. doi:10.1016/j.bjps.2021.11.004 PubMed
50. [50] Anthony Moussa et al.. J Am Acad Dermatol. 2022. Bicalutamide improves minoxidil-induced hypertrichosis in female pattern hair loss: A retrospective review of 35 patients. doi:10.1016/j.jaad.2021.10.048 PubMed
51. [51] Marko Kumric et al.. J Pers Med. 2022. Chronic Effects of Effective Oral Cannabidiol Delivery on 24-h Ambulatory Blood Pressure and Vascular Outcomes in Treated and Untreated Hypertension … doi:10.3390/jpm12071037 PubMed
52. [52] Xuelei Liang et al.. Front Med (Lausanne). 2022. Efficacy and Safety of 5% Minoxidil Alone, Minoxidil Plus Oral Spironolactone, and Minoxidil Plus Microneedling on Female Pattern Hair Loss: … doi:10.3389/fmed.2022.905140 PubMed
53. [53] Yao Zhang et al.. J Cosmet Dermatol. 2022. Randomized trial of microneedling combined with 2% minoxidil topical solution for the treatment of female pattern hair loss in a … doi:10.1111/jocd.15424 PubMed
54. [54] Ghada F R Hassan et al.. J Cosmet Dermatol. 2022. Treatment with oral vitamin D alone, topical minoxidil, or combination of both in patients with female pattern hair loss: A … doi:10.1111/jocd.14743 PubMed
55. [55] Jay D Modha et al.. J Cosmet Dermatol. 2022. Comprehensive review of oral minoxidil in alopecia. doi:10.1111/jocd.15324 PubMed
56. [56] Ralph M Trüeb et al.. J Am Acad Dermatol. 2022. Comment on "Bicalutamide Improves Minoxidil-Induced Hypertrichosis in Female Pattern Hair Loss: A Retrospective Review of 35 Patients". doi:10.1016/j.jaad.2022.01.054 PubMed
57. [57] Karolina Kozicka et al.. Postepy Dermatol Alergol. 2022. Scalp vascularization as a marker of topical minoxidil treatment efficacy in patients with androgenetic alopecia. doi:10.5114/ada.2021.103301 PubMed
58. [58] Jacob Griggs et al.. J Am Acad Dermatol. 2021. Pediatric androgenetic alopecia: A review. doi:10.1016/j.jaad.2019.08.018 PubMed
59. [59] Bevin Bhoyrul et al.. JAMA Dermatol. 2021. Clinicopathologic Characteristics and Response to Treatment of Persistent Chemotherapy-Induced Alopecia in Breast Cancer Survivors. doi:10.1001/jamadermatol.2021.3676 PubMed
60. [60] Ibrahim M Ibrahim et al.. J Cosmet Dermatol. 2021. Pumpkin seed oil vs. minoxidil 5% topical foam for the treatment of female pattern hair loss: A randomized comparative trial. doi:10.1111/jocd.13976 PubMed
61. [61] Sadegh Vahabi-Amlashi et al.. Dermatol Ther. 2021. A randomized clinical trial on therapeutic effects of 0.25 mg oral minoxidil tablets on treatment of female pattern hair loss. doi:10.1111/dth.15131 PubMed
62. [62] Santo Raffaele Mercuri et al.. Medicina (Kaunas). 2021. Investigating the Safety and Efficacy of Platelet-Rich Plasma (PRP) Treatment for Female Androgenetic Alopecia: Review of the Literature. doi:10.3390/medicina57040311 PubMed
63. [63] Yang Liu et al.. Lasers Med Sci. 2021. Comparison of low-level light therapy and combination therapy of 5% minoxidil in the treatment of female pattern hair loss. doi:10.1007/s10103-020-03157-1 PubMed
64. [64] Peter R Feldman et al.. EClinicalMedicine. 2021. Safety and efficacy of ALRV5XR in women with androgenetic alopecia or telogen effluvium: A randomised, double-blinded, placebo-controlled clinical trial. doi:10.1016/j.eclinm.2021.100978 PubMed
65. [65] Michela Starace et al.. Am J Clin Dermatol. 2020. Female Androgenetic Alopecia: An Update on Diagnosis and Management. doi:10.1007/s40257-019-00479-x PubMed
66. [66] Wimolsiri Iamsumang et al.. Drug Des Devel Ther. 2020. Finasteride and Its Potential for the Treatment of Female Pattern Hair Loss: Evidence to Date. doi:10.2147/DDDT.S240615 PubMed
67. [67] Ajay N Sharma et al.. Int J Dermatol. 2020. Low-dose oral minoxidil as treatment for non-scarring alopecia: a systematic review. doi:10.1111/ijd.14933 PubMed
68. [68] Yasmeen Jabeen Bhat et al.. Indian Dermatol Online J. 2020. Female Pattern Hair Loss-An Update. doi:10.4103/idoj.IDOJ_334_19 PubMed
69. [69] R Sinclair et al.. J Eur Acad Dermatol Venereol. 2020. Treatment of male and female pattern hair loss with sublingual minoxidil: a retrospective case-series of 64 patients. doi:10.1111/jdv.16616 PubMed
70. [70] Rita Rodrigues-Barata et al.. Skin Appendage Disord. 2020. Low-Dose Oral Minoxidil for Female Pattern Hair Loss: A Unicenter Descriptive Study of 148 Women. doi:10.1159/000505820 PubMed
71. [71] Alfredo Rossi et al.. Dermatol Pract Concept. 2020. Efficacy of Topical Finasteride 0.5% vs 17α-Estradiol 0.05% in the Treatment of Postmenopausal Female Pattern Hair Loss: A Retrospective, Single-Blind … doi:10.5826/dpc.1002a39 PubMed
72. [72] Maja Kovacevic et al.. J Cosmet Dermatol. 2020. Novel "After Minoxidil" spray improves topical minoxidil compliance and hair style manageability. doi:10.1111/jocd.13630 PubMed
73. [73] Enrico Carmina et al.. J Clin Endocrinol Metab. 2019. Female Pattern Hair Loss and Androgen Excess: A Report From the Multidisciplinary Androgen Excess and PCOS Committee. doi:10.1210/jc.2018-02548 PubMed
74. [74] Poonkiat Suchonwanit et al.. Am J Clin Dermatol. 2019. Efficacy of Topical Combination of 0.25% Finasteride and 3% Minoxidil Versus 3% Minoxidil Solution in Female Pattern Hair Loss: A … doi:10.1007/s40257-018-0387-0 PubMed
75. [75] Michela Starace et al.. J Cosmet Dermatol. 2019. Platelet-rich plasma on female androgenetic alopecia: Tested on 10 patients. doi:10.1111/jocd.12550 PubMed
76. [76] Calvin T. Sung et al.. J Drugs Dermatol. 2019. The Efficacy of Topical Minoxidil for Non-Scarring Alopecia: A Systematic Review. PubMed
77. [77] C Pindado-Ortega et al.. Actas Dermosifiliogr (Engl Ed). 2019. RF - Oral Minoxidil for Female Pattern Hair Loss and Other Alopecias. doi:10.1016/j.ad.2018.06.019 PubMed
78. [78] Karolina Kozicka et al.. Pol Merkur Lekarski. 2019. Methods of treatment patients with androgenetic alopecia based on reference of Department of Dermatology in Cracow. PubMed
79. [79] Rodney D Sinclair. Int J Dermatol. 2018. Female pattern hair loss: a pilot study investigating combination therapy with low-dose oral minoxidil and spironolactone. doi:10.1111/ijd.13838 PubMed
80. [80] G Fabbrocini et al.. Int J Womens Dermatol. 2018. Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review. doi:10.1016/j.ijwd.2018.05.001 PubMed
81. [81] A K Gupta et al.. J Eur Acad Dermatol Venereol. 2018. Efficacy of non-surgical treatments for androgenetic alopecia: a systematic review and network meta-analysis. doi:10.1111/jdv.15081 PubMed
82. [82] Motomu Manabe et al.. J Dermatol. 2018. Guidelines for the diagnosis and treatment of male-pattern and female-pattern hair loss, 2017 version. doi:10.1111/1346-8138.14470 PubMed
83. [83] Mauro Barbareschi. G Ital Dermatol Venereol. 2018. The use of minoxidil in the treatment of male and female androgenetic alopecia: a story of more than 30 years. doi:10.23736/S0392-0488.17.05781-9 PubMed
84. [84] Linda Chan et al.. Aust J Gen Pract. 2018. Female pattern hair loss. doi:10.31128/AJGP-02-18-4498 PubMed
85. [85] Esther J van Zuuren et al.. JAMA Dermatol. 2017. Interventions for Female Pattern Hair Loss. doi:10.1001/jamadermatol.2016.5790 PubMed
86. [86] Eshini Perera et al.. F1000Res. 2017. Treatment of chronic telogen effluvium with oral minoxidil: A retrospective study. doi:10.12688/f1000research.11775.1 PubMed
87. [87] Sung Jay Choe et al.. Ann Dermatol. 2017. Therapeutic Efficacy of a Combination Therapy of Topical 17α-Estradiol and Topical Minoxidil on Female Pattern Hair Loss: A Noncomparative, Retrospective … doi:10.5021/ad.2017.29.3.276 PubMed
88. [88] Ph Paquet et al.. Rev Med Liege. 2017. [What is the value of low-energie lasers in the treatment of androgenetic alopecia ?]. PubMed
89. [89] J McCoy et al.. J Biol Regul Homeost Agents. 2016. Minoxidil dose response study in female pattern hair loss patients determined to be non-responders to 5% topical minoxidil. PubMed
90. [90] Ulrike Blume-Peytavi et al.. J Drugs Dermatol. 2016. Efficacy and Safety of Once-Daily Minoxidil Foam 5% Versus Twice-Daily Minoxidil Solution 2% in Female Pattern Hair Loss: A Phase … PubMed
91. [91] Michelangelo La Placa et al.. Skin Appendage Disord. 2016. Scalp Psoriasiform Contact Dermatitis with Acute Telogen Effluvium due to Topical Minoxidil Treatment. doi:10.1159/000441622 PubMed
92. [92] Esther J van Zuuren et al.. Cochrane Database Syst Rev. 2016. Interventions for female pattern hair loss. doi:10.1002/14651858.CD007628.pub4 PubMed
93. [93] J McCoy et al.. J Biol Regul Homeost Agents. 2016. Doppler laser imaging predicts response to topical minoxidil in the treatment of female pattern hair loss. PubMed
94. [94] Amy McMichael et al.. J Drugs Dermatol. 2016. Efficacy and Safety of Minoxidil 2% Solution in Combination With a Botanical Hair Solution in Women With Female Pattern Hair … PubMed
95. [95] Wilma Bergfeld et al.. J Drugs Dermatol. 2016. A Phase III, Multicenter, Parallel-Design Clinical Trial to Compare the Efficacy and Safety of 5% Minoxidil Foam Versus Vehicle in … PubMed
96. [96] Jay C Vary. Med Clin North Am. 2015. Selected Disorders of Skin Appendages--Acne, Alopecia, Hyperhidrosis. doi:10.1016/j.mcna.2015.07.003 PubMed
97. [97] Omar A Masri et al.. World J Gastroenterol. 2015. Role of vitamins in gastrointestinal diseases. doi:10.3748/wjg.v21.i17.5191 PubMed
98. [98] Fernanda Torres et al.. Semin Cutan Med Surg. 2015. Female pattern alopecia and telogen effluvium: figuring out diffuse alopecia. doi:10.12788/j.sder.2015.0142 PubMed
99. [99] Nicole E Rogers. Semin Cutan Med Surg. 2015. Hair transplantation update. doi:10.12788/j.sder.2015.0131 PubMed
100. [100] Katya L Harfmann et al.. Clin Obstet Gynecol. 2015. Hair loss in women. doi:10.1097/GRF.0000000000000081 PubMed
101. [101] Dimitrios Ioannides et al.. Curr Probl Dermatol. 2015. Female pattern hair loss. doi:10.1159/000369404 PubMed
102. [102] Andréia Munck et al.. Int J Trichology. 2014. Use of low-level laser therapy as monotherapy or concomitant therapy for male and female androgenetic alopecia. doi:10.4103/0974-7753.138584 PubMed
103. [103] Aditya K Gupta et al.. Skin Therapy Lett. 2014. 5% Minoxidil: treatment for female pattern hair loss. PubMed
104. [104] Shannon Famenini et al.. J Drugs Dermatol. 2014. Evidence for supplemental treatments in androgenetic alopecia. PubMed
105. [105] Nicolas Perez-Mora et al.. Dermatol Ther. 2014. Acute telogen effluvium onset event is associated with the presence of female androgenetic alopecia: potential therapeutic implications. doi:10.1111/dth.12101 PubMed
106. [106] Nusrat Banka et al.. Dermatol Clin. 2013. Pattern hair loss in men: diagnosis and medical treatment. doi:10.1016/j.det.2012.08.003 PubMed
107. [107] Natasha Atanaskova Mesinkovska et al.. Dermatol Clin. 2013. Hair: what is new in diagnosis and management? Female pattern hair loss update: diagnosis and treatment. doi:10.1016/j.det.2012.08.005 PubMed
108. [108] Ingrid Herskovitz et al.. Int J Endocrinol Metab. 2013. Female pattern hair loss. doi:10.5812/ijem.9860 PubMed
109. [109] Xiao-Sheng Zhuang et al.. Exp Ther Med. 2013. Quality of life in women with female pattern hair loss and the impact of topical minoxidil treatment on quality of … doi:10.3892/etm.2013.1126 PubMed
110. [110] Archana Singal et al.. Indian J Dermatol Venereol Leprol. 2013. Female pattern hair loss. doi:10.4103/0378-6323.116732 PubMed
111. [111] Lauren L Levy et al.. Int J Womens Health. 2013. Female pattern alopecia: current perspectives. doi:10.2147/IJWH.S49337 PubMed
112. [112] E J van Zuuren et al.. Br J Dermatol. 2012. Evidence-based treatments for female pattern hair loss: a summary of a Cochrane systematic review. doi:10.1111/j.1365-2133.2012.11166.x PubMed
113. [113] Esther J van Zuuren et al.. Cochrane Database Syst Rev. 2012. Interventions for female pattern hair loss. doi:10.1002/14651858.CD007628.pub3 PubMed
114. [114] Masoumeh Hassani et al.. Skinmed. 2012. Treatment of female pattern hair loss. PubMed
115. [115] R Sinclair et al.. Br J Dermatol. 2011. Hair loss in women: medical and cosmetic approaches to increase scalp hair fullness. doi:10.1111/j.1365-2133.2011.10630.x PubMed
116. [116] Anosha Yazdabadi et al.. Australas J Dermatol. 2011. Treatment of female pattern hair loss with the androgen receptor antagonist flutamide. doi:10.1111/j.1440-0960.2010.00735.x PubMed
117. [117] Deepani Rathnayake et al.. Dermatol Clin. 2010. Innovative use of spironolactone as an antiandrogen in the treatment of female pattern hair loss. doi:10.1016/j.det.2010.03.011 PubMed
118. [118] Mahyar Ghanaat. South Med J. 2010. Types of hair loss and treatment options, including the novel low-level light therapy and its proposed mechanism. doi:10.1097/SMJ.0b013e3181ebcf71 PubMed
119. [119] Stephen M Stout et al.. Ann Pharmacother. 2010. Finasteride treatment of hair loss in women. doi:10.1345/aph.1M591 PubMed
120. [120] Shyam Behari Shrivastava. Indian J Dermatol Venereol Leprol. 2009. Diffuse hair loss in an adult female: approach to diagnosis and management. doi:10.4103/0378-6323.45215 PubMed
121. [121] Francisco M Camacho-Martínez. Semin Cutan Med Surg. 2009. Hair loss in women. doi:10.1016/j.sder.2009.01.001 PubMed
122. [122] Anne L Mounsey et al.. Am Fam Physician. 2009. Diagnosing and treating hair loss. PubMed
123. [123] . Harv Womens Health Watch. 2009. Treating female pattern hair loss. Noticeable hair loss can be deeply distressing. Here are some medical treatments that may help. PubMed
124. [124] Nicole E Rogers et al.. J Am Acad Dermatol. 2008. Medical treatments for male and female pattern hair loss. doi:10.1016/j.jaad.2008.07.001 PubMed
125. [125] Noah Scheinfeld. Dermatol Online J. 2008. A review of hormonal therapy for female pattern (androgenic) alopecia. PubMed
126. [126] Matt Leavitt. Facial Plast Surg. 2008. Understanding and management of female pattern alopecia. doi:10.1055/s-0028-1102905 PubMed
127. [127] Carlijn Hoedemaker et al.. Australas J Dermatol. 2007. Treatment of female pattern hair loss with a combination of spironolactone and minoxidil. doi:10.1111/j.1440-0960.2007.00332.x PubMed
128. [128] Quan Q Dinh et al.. Clin Interv Aging. 2007. Female pattern hair loss: current treatment concepts. PubMed
129. [129] Matti Hannuksela. Duodecim. 2006. [The treatment of female pattern hair loss]. PubMed
130. [130] Elise A Olsen et al.. J Am Acad Dermatol. 2005. Evaluation and treatment of male and female pattern hair loss. doi:10.1016/j.jaad.2004.04.008 PubMed
131. [131] R Sinclair et al.. Br J Dermatol. 2005. Treatment of female pattern hair loss with oral antiandrogens. doi:10.1111/j.1365-2133.2005.06218.x PubMed
132. [132] Anne W Lucky et al.. J Am Acad Dermatol. 2004. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss. doi:10.1016/j.jaad.2003.06.014 PubMed
133. [133] Vera H Price. J Investig Dermatol Symp Proc. 2003. Androgenetic alopecia in women. doi:10.1046/j.1523-1747.2003.12168.x PubMed
134. [134] M P Birch et al.. Clin Exp Dermatol. 2002. Female pattern hair loss. doi:10.1046/j.1365-2230.2002.01085.x PubMed
135. [135] R M Trüeb. Ther Umsch. 2002. [Diffuse hair loss in women]. doi:10.1024/0040-5930.59.5.217 PubMed
136. [136] S Rand. J Am Acad Dermatol. 1997. Chronic telogen effluvium: potential complication for clinical trials in female androgenetic alopecia? doi:10.1016/s0190-9622(97)70099-9 PubMed